Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRNS | ZTS | TAK | CTLT | NBIX |
| Company | Marinus Pharma CS | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Catalent Inc | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NASDAQ |
| Open | 1.4500 | 146.25 | 13.37 | 56.00 | 141.00 |
| High | 1.5600 | 149.90 | 13.41 | 56.19 | 145.00 |
| Low | 1.3950 | 145.18 | 13.30 | 55.83 | 139.22 |
| Last | 1.4400 | 149.56 | 13.38 | 56.03 | 140.09 |
| Change | -0.0350 | +4.02 | +0.02 | -0.02 | +6.43 |
| % Change | -2.37% | +2.76% | +0.15% | -0.04% | +4.81% |
| Volume | 2,871,800 | 4,315,200 | 1,702,400 | 1,575,900 | 1,607,800 |
| 20-Day Average Volume | 4,483,925 | 4,148,760 | 1,820,815 | 1,606,800 | 797,445 |
| Previous Close | 1.4750 | 145.54 | 13.36 | 56.05 | 133.66 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.9728 | 159.40 | 13.54 | 56.38 | 136.67 |
| 20-Day Raw Stochastic | 3.98% | 18.07% | 20.15% | 34.27% | 66.98% |
| 20-Day Relative Strength | 17.91% | 32.61% | 39.08% | 50.98% | 55.97% |
| Weighted Alpha | -35.95 | -21.01 | -19.42 | +36.89 | +41.20 |
| Today's Opinion | 88% Sell | 88% Sell | 100% Sell | 40% Buy | 96% Buy |
| Previous Opinion | 72% Sell | 88% Sell | 100% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 56% Sell | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +20.00% since 04/16/24 | -2.26% since 04/16/24 | +1.13% since 04/16/24 | +0.45% since 04/16/24 | +5.34% since 04/16/24 |
| Low | 1.1600 on 04/17/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 55.42 on 04/19/24 | 130.13 on 04/19/24 |
| High | 1.5600 on 04/23/24 | 153.67 on 04/18/24 | 13.41 on 04/23/24 | 56.53 on 04/18/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -83.65% since 03/22/24 | -11.45% since 03/22/24 | -7.15% since 03/22/24 | +0.43% since 03/22/24 | -0.95% since 03/22/24 |
| Low | 1.1100 on 04/16/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 55.42 on 04/19/24 | 130.13 on 04/19/24 |
| High | 9.4100 on 03/26/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 57.20 on 04/11/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | -85.53% since 01/23/24 | -20.49% since 01/23/24 | -9.16% since 01/23/24 | +13.88% since 01/23/24 | -0.23% since 01/23/24 |
| Low | 1.1100 on 04/16/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 49.24 on 01/24/24 | 128.00 on 02/07/24 |
| High | 10.5000 on 03/01/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 60.20 on 02/05/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | -78.02% since 10/23/23 | -10.17% since 10/23/23 | -7.85% since 10/23/23 | +32.71% since 10/23/23 | +29.82% since 10/23/23 |
| Low | 1.1100 on 04/16/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 31.80 on 11/01/23 | 103.63 on 11/10/23 |
| High | 11.2600 on 01/08/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 60.20 on 02/05/24 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 81,023 | 66,564,024 | 42,281,968 | 10,143,592 | 13,300,106 |
| Shares Outstanding, K | 54,931 | 457,359 | 3,164,818 | 180,974 | 99,507 |
| Annual Sales | 30,990,000 | 8,544,000,000 | 29,803,340,000 | 4,263,000,000 | 1,887,100,000 |
| Annual Net Income | -141,410,000 | 2,344,000,000 | 2,345,930,000 | -256,000,000 | 249,700,000 |
| Last Quarter Sales | 7,190,000 | 2,213,000,000 | 7,556,070,000 | 1,024,000,000 | 515,200,000 |
| Last Quarter Net Income | -41,770,000 | 525,000,000 | 718,900,000 | -206,000,000 | 147,700,000 |
| 60-Month Beta | 0.91 | 0.85 | 0.53 | 1.20 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 03/05/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | -0.24 on 02/09/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/09/24 | 06/10/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.54 | 6.79 | 0.00 | 54.55 |